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Abstract
Background Couples coping with colorectal cancer were
monitored during the first year after diagnosis to evaluate
the following: (i) levels of patients’ and partners’ fatigue—
hereby comparing their scores to each other and a normative
population, (ii) association between patients’ and partners’
fatigue, (iii) the course of partners’ fatigue, and (iv)
biopsychosocial predictors of the partners’ fatigue, including
the patients’ level of fatigue.
Method Couples (n = 171) preoperatively completed ques-
tions regarding age and sex as well as questionnaires assessing
neuroticism and trait anxiety. Questionnaires assessing fa-
tigue, anxiety, and depressive symptoms were measured pre-
operative (time-0) and 3 (time-1), 6 (time-2), and 12 months
(time-3) postoperative. Patients’ clinical characteristics were
retrieved from the Eindhoven Cancer Registry. Descriptive
statistics, correlations, and linear mixed effect models were
used.
Results Compared with a normative population, partners’ fa-
tigue was similar (p > .05), while patients’ fatigue was higher
at Time-2 and Time-3 (p values <.001). At each time point,
correlations between patients’ and partners’ fatigue were small
(r < .30). Partner’s course of fatigue was as follows: 18.2 at
time-0, 19.0 at time-1, 19.4 at time-2, and 19.2 at time-3
(p = 0.64). Scoring higher on neuroticism (β = .12) and trait
anxiety (β = .23), and more depressive symptoms (β = .30)
significantly contributed to higher partners’ fatigue.
Conclusion Trait anxiety, neuroticism, and depressive symp-
toms predicted higher levels of partners’ fatigue, while demo-
graphic factors, patients’ fatigue, and clinical factors did not.
Health professionals are advised to be alert for partners with a
vulnerable personality and depressive symptoms. If needed,
they can for instance refer to a psychologist for treatment.
Keywords Colorectal . Fatigue . Partners . Interdependency .
Caregiver
Introduction
Fatigue is known as one of the most disturbing and long-
lasting consequences of cancer treatment. [1–3] The
National Comprehensive Cancer Network (NCCN) defined
cancer-related fatigue as B…a distressing persistent, subjective
sense of physical, emotional and/or cognitive tiredness related
to cancer or cancer treatment that is not proportional to recent
activity and interferes with usual functioning.^ [4] This defi-
nition shows that cancer-related fatigue is a subjective, com-
plex, andmultidimensional construct. A recent review showed
that there are several factors that can influence cancer-related
fatigue including genetic risk factors (single nucleotide poly-
morphisms (SNPs) in inflammation-related genes), psychoso-
cial factors (pre-treatment fatigue, depressive symptoms, sleep
disturbance, dysfunctional coping and appraisal processes,
loneliness, early life stress), and biobehavioral factors (phys-
ical inactivity, elevated body mass index) [5]. The percentage
of patients that reports to be fatigued varies across studies,
from 15 % [6] to 99 % [7], which is partly due to the
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methodological differences between studies. [8] Cancer-
related fatigue poses challenges on several levels: (i) for the
individual, such as being able to adequately perform daily
activities [7, 9] and/or an impaired quality of life [10]; (ii)
for employers due to decreased work ability and increased
sick leave [11, 12]; and (iii) for the health care system as
fatigued patients show an increased health care consumption
[13]. Therefore, there are numerous studies dedicated to iden-
tifying the level and predictors of cancer-related fatigue
[14–16] and evaluating interventions addressing this fatigue
using pharmacologic agents [17], exercise [18, 19], or psycho-
social counseling [20].
However, a diagnosis and treatment of cancer not only
affects the patient but also the partner. [21] Partners also have
to incorporate ongoing cancer-related experiences into their
lives, as the patients’ functioning may influence the partners
functioning and vice versa. [21] Moreover, partners are often
faced with the care of the patient. Awide variety of caregiving
activities exist, which can vary from providing instrumental
(e.g., assistance with self-care) to emotional care (e.g., provid-
ing social support) [22]. The term caregiver burden is used to
describe the burden associated with caring for a loved one. It
entails the physical, psychological, social, and/or financial
reactions that can be experienced when giving care. [22] In
this regard, physical problems, such as pain and sleep prob-
lems, are prevalent among partners taking care of the patient
[23]. In addition, higher levels of distress have been found in
partners of patients with cancer, when comparing them with a
normative population. [24–27] Some studies even reported
that the distress experienced by the partners is greater than
the distress reported by the patients themselves. [28, 29]
Furthermore, partners may have to reduce their working ca-
pacity in order to provide care, which can result in (additional)
financial problems. [30, 31] Finally, partners may experience
social challenges, as there is less time and energy available for
social interactions. [23] This abovementioned studies show
that the biopsychosocial consequences of the patients’ illness
for the partners have been evaluated to some extent.
However, to our knowledge, limited studies have been con-
ducted evaluating partners’ fatigue and the association be-
tween patients’ and partners’ experienced fatigue. This is re-
markable considering that fatigue is the most prominent con-
sequence for patients and may, due to the shared experience
and bi-directional influence of patients and partners, potential-
ly play a major role for the partners as well. Moderate to
severe levels of fatigue were reported in caregivers of patients
with cancer [32] as well as a significant positive correlation in
the couples levels of fatigue in both patient with breast and
prostate cancer [33]. However, the 6-month follow-up study
of Peters et al. (2015) found no significant association be-
tween patients and caregivers levels of fatigue. [34]
However, they did report that fatigue in both patients and
caregivers was associated with higher caregiver burden [34].
In addition, Jensen and Given (1993) [35] reported no signif-
icant correlation between the severity of fatigue experienced
by the caregiver and his/her age, employment status, the num-
ber of hours of daily caregiving or its duration, while a signif-
icant correlation was found between fatigue of the caregiver
and the impact of care on the daily schedule.
However, evaluating partners may be especially interesting
as they are most close to the patient. In addition, they often
face their own health issues as they are often roughly the same
age as the patients. Therefore, they may be especially at risk
for developing problems, such as fatigue. Therefore, it is in-
teresting to evaluate the association between patients and part-
ners fatigue and the level of the partners’ fatigue over a longer
period of time. In addition, biopsychosocial predictors of the
partners’ fatigue have not yet been identified. The current
study aimed to evaluate the following: (i) association between
the patients and partners fatigue, (ii) the course of partners’
fatigue during the first year after diagnosis, and (iii)
biopsychosocial predictors of the partners’ fatigue, including
the patients’ level of fatigue, across time. In order to answer
these research questions, a not yet evaluated population was
evaluated, i.e., the partners of patients coping with colorectal
cancer treated with curative intent.
Methods
Participants
Data were drawn from a larger study examining the (sexual)
consequences of colorectal cancer for patients and their part-
ners (NCT01234246). For this study, patients and partners
were invited to participate. They were recruited from six
Dutch hospitals: St. Elisabeth Hospital (Tilburg),
TweeSteden Hospital (Tilburg and Waalwijk), Catharina
Hospital (Eindhoven), Jeroen Bosch Hospital (‘s
Hertogenbosch), Amphia Hospital (Breda), and Maxima
Medical Centre (Eindhoven and Veldhoven). Patients were
excluded if one or more of the following criteria was applica-
ble: (i) elderly age (>75 years), (ii) non-curatively treated me-
tastases at baseline, (iii) poor expression of the Dutch lan-
guage, (iv) dementia, and/or (v) a history of psychiatric illness.
Partners with (i) insufficient knowledge of the Dutch language
and (ii) dementia or a history of psychiatric illness were ex-
cluded. During a preoperative visit, eligible patients and part-
ners were asked, by their treating physician, if they gave per-
mission to be approached by a member of the research team.
Partners were able to participate even if patients declined par-
ticipation and vice versa, in order to prevent selection bias.
Subsequently, a member of the research team contacted po-
tential participants by phone to explain the design and purpose
of the study. If patients and/or partners agreed to participate,
they were asked to complete a set of questionnaires at home
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before surgery (time-0) and three (time-1), six (time-2), and
12 months (time-3) postoperative. However, at the time of the
study, the Dutch guidelines recommended that all patients
with rectal cancer, except those with a clinical T1 stage with-
out positive lymph nodes, receive neoadjuvant treatments
(i.e., radio(chemo)therapy; www.oncoline.nl). Therefore, a
subset of patients and partners completed the first set of
questionnaires prior to surgery, but potentially during or
after the time patients received neoadjuvant therapy. Patients
and partners returned the surveys in sealed postage-paid en-
velopes. Patients and partners who did not return the question-
naires within 2 weeks received reminders (phone call(s) and/
or a reminder letter). The study was approved by the institu-
tional review board. All participants gave written informed
consent. As this specific study evaluated the correlation be-
tween patients and partners’ levels of fatigue and patient-
related influences on the partners’ fatigue, only participating
couples were included in the current sample.
Measures
The patient’s clinical information was retrieved from the
Eindhoven Cancer Registry (ECR). The ECR routinely col-
lects data on tumor characteristics and treatment. Patients and
partners also completed questions regarding their age, sex, and
length of the relationship with their partner. The following
psychosocial constructs were examined:
For both patients and partners, fatigue was evaluated with
the Fatigue Assessment Scale (FAS) [36]. The FAS is a gener-
ic questionnaire assessing perceived fatigue and exhaustion
with ten items. The response scale is a five-point scale ranging
from 1 (never) to 5 (always) and total scores can range from
10 to 50. Total scores can be divided into two groups: not
fatigued (a score of 10 to 21) and fatigued (a score of 22 to
50) [36]. The psychometric properties are good. [36]
Two aspects of the partners’ personality were assessed.
Neuroticism was assessed with the neuroticism facet of the
Neuroticism-Extraversion-Openness-Five Factor Inventory
(NEO-FFI) [37]. This factor assesses six aspects belonging
to neuroticism (i.e., anxiety, hostility, depression, self-con-
sciousness, impulsiveness, vulnerability to stress). Trait anxi-
ety was evaluated with the Dutch short form trait scale of the
Spielberger State-Trait Anxiety Inventory (STAI) [38]. The
trait anxiety scale describes how persons generally feel and
conceives anxiety as a personality disposition [38].
Partners’ psychological function was assessed with two
constructs. Depressive symptoms were evaluated with the
16-item version of the Center for Epidemiological Studies-
Depression Scale (CES-D) [14]. State anxiety was assessed
with the short form (6-items) of the STAI state anxiety scale.
[39] State anxiety is a momentary emotional condition char-
acterized by subjective feelings of apprehension and tension
and heightened autonomic nervous system activity and may
thus vary in intensity and fluctuate over time. [39]
Sociodemographic factors and personality characteristics
were assessed only at time-0, while all other questionnaires
were completed at each time point (time-0–time-3). The psy-
chometric properties of all questionnaires were satisfactory.
Statistical analyses
An independent t test and chi-square tests were used to exam-
ine potential differences in age, sex, and type of tumor. Paired-
samples t tests were performed to evaluate the level of fatigue
between patients and partners. Next, the percentage of fa-
tigued patients and partners at each time point was deter-
mined, using the cut-off scores. Levels of fatigue for patients
and partners were compared with previously reported norma-
tive scores. [36] In addition, bivariate correlations between (i)
the levels of fatigue at the different time points for both pa-
tients and partners separately and (ii) patients’ fatigue and
partners’ fatigue at each time point were assessed with the
Pearson product-moment correlat ion coefficient .
Correlations were grouped into small (r = <.30), moderate
(r = .30–.49), or high (r > .49) [40].
Linear mixed-effects models with an unstructured error co-
variance pattern model were used to examine the course of
fatigue and predictors for fatigue. Time was analyzed as a
categorical predictor with four levels (i.e., time-0, time-1,
time-2, and time-3). The fixed-effects parameters of the
models were estimated with maximum likelihood.
Sociodemographic variables (i.e., age, sex), patient-related
variables (i.e., type of surgery, radiotherapy (yes/no), chemo-
therapy (yes/no), chemoradiation (yes/no), and the patients’
level of fatigue), and personality characteristics (i.e., trait anx-
iety and neuroticism) were analyzed as time-invariant predic-
tors as they were only assessed at baseline. Psychological
variables (i.e., anxiety and depressive symptoms) were mea-
sured at each time point and analyzed as time-varying predic-
tors. [41] A forward selection procedure was chosen. In order
to determine the final model, separate sets of predictors were
evaluated first. The following sets were formed: age and sex
(block 1), personality characteristics (block 2), psychological
variables (block 3), and clinical characteristics (block 4).
These sets were formed based on content. To minimize data-
driven choices and to identify the parsimonious model, a
p < .10 was used during the selection procedure. Next, the
selected variables were analyzed in one final model.
Furthermore, for this final model, significant effects for the
time-varying predictors were split into two effects: between-
subjects effects (e.g., the degree to which patients’ fatigue is
related to their average level on a predictor) and within-
subjects effects (e.g., the degree to which variation in patients’
fatigue over time is associated with a change in their levels on
a predictor) [41]. In order to correctly interpret all model pa-
rameters, all time-varying variables have been grand-mean
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centered. Analyses were performed in IBM SPSS 22.0, using
a significance level of p < .05 (with the exception of the se-
lection procedure). Means and standard deviations are report-
ed as mean ± SD.
Results
In total, 743 eligible patients agreed to be contacted by a
member of the research group, who informed them about the
study. Fewer women (n = 280, 39 %) than men (n = 445,
62 %) were approached (for 18 patients (2 %) information
regarding their sex was missing). Of the approached patients,
354 (48 %) agreed to participate, 232 (66 %) men and 122
(34 %) women. Various reasons for declining or terminating
participation were reported. The most reported reasons for
non-participation were (1) the intimate nature of the question-
naires, (2) the length of the questionnaires, and (3) the amount
of experienced stress at that time. More men (52 %) than
women (43 %) agreed to participate (p = .033). The average
age of participants (62.5 ± 8.5) and non-participants
(63.7 ± 9.9) did not differ (p = 0.84). Of the 354 patients,
318 (90 %) had a partner of which 229 (65 %) participated.
In addition, four partners participated even though the patient
did not. However, due to the dyadic nature of this study, they
were not included. An overview of couples that participated at
each time point is presented in Fig. 1. Not all couples com-
pleted all assessments. To be included in the analyses couples
had to complete at least two assessments. Based on this crite-
rion, 171 (75 %) couples were included in the analyses. An
overview of the sociodemographic, clinical, and psychologi-
cal characteristics of the participating couples is presented in
Table 1.
Levels of fatigue and correlations between time points
and patients and partners
At time-1 and time-2, partners had significantly lower levels
of fatigue than patients (Table 2, p = .001 and p = .004,
respectively). At these time points, approximately one third
of the partners scored above the cut-off score for fatigue, as
did nearly half of the patients (Table 3). Compared with a
normative population, the partners’ levels of fatigue were
comparable at each time point (p values >.05). However, pa-
tients reported higher levels of fatigue compared with a nor-
mative population at time-1 and time-2 (p values <.001).
For partners, there were high correlations between the
levels of fatigue across the several time points (r values be-
tween r = .53 and r = .66), with the exception of the correlation
between time-0 and time-3, which was moderate (r = .36). For
patients, the correlations between the levels of fatigue were
moderate (r values between r = .31 and r = .50), except for the
correlation between time-0 and time-1, which was high
(r = .50). Correlations between the levels of fatigue between
patients and partners at each time point were low and only
significant at time-2 (r = .20, p = .02).
Course and biopsychosocial predictors of the partners’
fatigue
The selection procedure showed that the partners’ trait anxiety
(p < .0001, block 2), neuroticism (p = .002, block 2), state
anxiety (p = .020, block 3), and depressive symptoms
(p < .0001, block 3) predicted the course and levels of the
partners’ fatigue and were, therefore, included in the final mod-
el (Table 3, part I). None of the partner’s sociodemographic
factors (block 1) or the patient’s clinical characteristics (block
4) predicted the course and levels of the partners’ fatigue (p
values >.05).
In the final model, the estimated marginal means showed
that the partner’s fatigue at time-0 was 18.2, which increased
0.8 points to 19.0 at time-1, then increased a little further to
19.4 at time-2, and finally decreased slightly to 19.2 at time-3
(p = 0.64, part I, Table 3). Only the partners’ fatigue scores at
time-2 (p = .016) and time-3 (p = .030) were significantly
higher than the partners’ fatigue scores at time-0. In this mod-
el, having neuroticism (β = .12, p = .039), having trait anxiety
(β = .23, p = .015), and having depressive symptoms (β = .30,
p < .0001) significantly contributed to a higher partners’
fatigue.
The between- and within-subjects analysis for the time-
varying predictor depressive symptoms (part II, Table 3)
showed that partners who on average had higher levels of
depressive symptoms had on average higher levels of fatigue
(between-subjects effect, β = .37, p < .0001). Moreover, part-
ners who showed a change in depressive symptoms on a time
point also showed a change in fatigue scores (within-subjects
effect, β = .26, p < .0001).
Discussion
From diagnosis until 1 year postoperative, the partners’ levels
of fatigue were comparable to levels reported in a normative
population. Patients reported more fatigue at 3 and 6 months
postoperative compared with partners and the normative pop-
ulation. From a clinical perspective, this is not surprising since
patients have to cope with cancer-related fatigue.
Furthermore, across time correlations between partners’ fa-
tigue scores were high, but correlations between the fatigue
scores of patients and partners were not. Moreover, the mixed
model analyses showed that the patients’ levels of fatigue
were not indicative of the partners’ levels of fatigue. The
abovementioned results are not in line with what was expected
based on the often reported interdependency between patients
and partners. [21] Higher levels of fatigue for the partners
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were expected as partners are faced with the multifaceted care
for the patients. Perhaps, partners are reluctant to acknowl-
edge the burden of the patients’ disease on their own function-
ing. Partners may have reported to be less fatigued than they
actually were. Especially, since the study did not explicitly
focus on fatigue as part of the caregiver burden. Perhaps other
factors may play a more prominent role in determining the
partners’ fatigue, such as daily hassles and the previously
reported impact of care on the daily schedule. [35] Two recent
studies also reported non-significant correlations between pa-
tients and partners’ fatigue [34, 42].
The personality characteristics trait anxiety and neuroti-
cism were identified as significant predictors for the partners’
fatigue. To our knowledge, this is the first study indicating the
role of personality characteristics in partners’ functioning. For
patients, the influence of trait anxiety [43] and neuroticism
[44] on their quality of life has been established. Perhaps,
certain personality characteristics, such as trait anxiety and
neuroticism, may make people more vulnerable for adverse
psychological outcomes, regardless of their status (i.e., patient
or partner). The same relationship may apply for depressive
symptoms. Depressive symptoms (both between- and within-
10 (4.4%) patients and 10 (4.4%) partners missing
35 (15.3%) patients and 42 (18.3%) partners 
dropped-out
10 (4.4%) partners and 9 (3.9%) partners missing,
35 (15.3%) patients and 42 (18.3%) partners 
already dropped-out at Time-1 
24 (10.5%) patients and 30 (13.1%) partners 
dropped-out at Time-2
173 (75.5%) patients and 177 (77.3%) 
partners completed Time-0
184 (80.3%) patients and 177 (77.3%) 
partners completed Time-1
160 (69.9%) patients and 148 (64.6%) 
partners completed Time-2
148 (64.6%) patients and 129 (56.3%) 
completed Time-3
2 (0.9%) patients and 5 (2.1%) partners missing,
35 (15.3%) patients and 42 (18.3%) partners 
already dropped-out at Time-1 
24 (10.5%) patients and 30 (13.1%) partners 
dropped-out at Time-2
16 (7.0%) patients and 22 (9.6%) partners dropped-
out at Time-3
4 (1.7%) patients and 2 (0.9%) partners not yet 
completed Time-3
In total, 229 couples participated
56 (24.5%) patients and 52 (22.7%) partners were 
unable to complete Time-0 (e.g., too little time 
between recruitment and surgery)
Fig. 1 Flow-chart of couples that
participated at each time point
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subjects) were a significant predictor of higher levels of part-
ners’ fatigue. For patients, the negative influence of depressive
symptoms on fatigue has been reported before [45, 46]. This
relationship was not yet evaluated for partners. However, the
depressive symptoms of partners have been associated with
their experienced caregiver burden [47]. In addition, there is a
well-known overlap of somatic symptoms of depression and
symptoms of fatigue, whichmay also explain this relationship.
The patient’s treatment-related characteristics did not influ-
ence the partners’ levels of fatigue. Even though only infor-
mation on whether or not a patient underwent a certain
treatment modality (i.e., surgery, chemotherapy and/or radio-
therapy) was available, these variables provided a rough indi-
cation of treatment burden. However, as all eligible patients
with colon or rectal cancer treated with curative intent were
included in this study, a wide variety of treatment schedules
occurred. However, the type of treatment patients were still
receiving during follow-up (time-1, time-2, and time-3) may
have influenced the levels of experienced fatigue. Being un-
able to clearly incorporate, the heterogeneity in clinical pro-
files may have prohibited the possibility to adequately deter-




Partners (n = 171) Patients (n = 171)
Mean ± SD Mean ± SD
Age at time of survey 60.9 ± 9.3 59.7 ± 16.1
Duration of relationship (year) 35.4 ± 17.0 34.9 ± 16.7
Neuroticism 29.3 ± 6.9 27.2 ± 7.0
Trait anxiety 17.3 ± 4.6 16.6 ± 4.8
State anxiety
Time-0 11.6 ± 3.3 11.2 ± 3.4
Time-1 11.1 ± 3.2 10.2 ± 3.1
Time-2 11.5 ± 3.3 10.0 ± 2.7
Time-3 10.5 ± 2.8 9.9 ± 3.2
Depressive symptoms
Time-0 6.8 ± 6.5 6.0 ± 6.7
Time-1 5.8 ± 6.3 5.7 ± 5.7
Time-2 5.7 ± 6.0 5.7 ± 6.2
Time-3 5.3 ± 5.9 4.7 ± 5.6
n (%) n (%)
Male sex 53 (31 %) 160 (70 %)
Type of cancer
Colon – 72 (42 %)
Rectum – 99 (58 %)
Surgery
Low anterior resection – 61 (36 %)
Abdominoperineal resection – 32 (19 %)
Hemicolectomy/ileocecal resection – 26 (15 %)
Sigmoid resection – 26 (15 %)
Other – 19 (11 %)
Unknown type of surgery – 7 (4 %)
Radiotherapy, yes – 45 (26 %)
Missing – 5 (3 %)
Chemoradiation, yes – 58 (34 %)
Missing – 5 (3 %)
Chemotherapy, yes – 48 (28 %)
Missing – 5 (3 %)
Stoma, yes – 93 (55 %)
Missing – 5 (3 %)
For eight patients, their clinical characteristics were not available. Neuroticism range = 12–60. Trait anxiety
range = 10–40. State anxiety range = 4–24. Depressive symptoms range = 0–48. Higher scores indicate more
problems
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Finally, age and gender were no significant predictors for the
experienced levels of fatigue. Thus, in this study, the partners’
fatigue was not determined by sociodemographic or the pa-
tient’s clinical characteristics, but only by personality and psy-
chological factors.
There are some additional critical remarks that need to be
acknowledged. This data were collected as part of a larger
study evaluating the (sexual) consequences of colorectal can-
cer. The sexual nature of this study made it difficult to recruit
participants, resulting in a 45 % response rate. Moreover, a
substantial number of drop-outs and/or missing data should be
noted. Other remarks concerning the generalizability of the
study are that the included sample predominantly consisted
of male, heterosexual, Caucasian participants and that elderly
patients (>75 years) were not recruited. Furthermore, the pre-
operative assessment should not be mistaken for a baseline
measurement, as the time between diagnosis and surgical
treatment can already be psychologically and physically chal-
lenging for patients and partners.
Regardless of the abovementioned limitations, this study pro-
vided insight in the level of the partners’ fatigue over a longer
period of time, relatedness between patients and partners’ levels
of fatigue, and predictors of partners’ fatigue. Especially the
finding that personality characteristics (i.e., high trait anxiety
and neuroticism) and depressive symptoms are indicative of
higher levels of partners’ fatigue is important. In clinical practice,
health professionals are advised to focus not solely on the patient
but also to evaluate the functioning of the partners. Especially,
partners with a high trait anxiety and neuroticism and depressive
symptoms may thus be at risk for fatigue. If psychological care
for the partner is needed, health professionals can for instance
refer them to a psychologist for adequate and timely treatment.
Moreover, optimizing the partners functioning may not only
benefit the partner, but the patient as well. Suboptimal adaptation
of the partner to the patient’s illness may negatively influence the
partners’ engagement in the patient’s care [48]. Furthermore, low
partner support can lead to less treatment adherence or fewer
favorable lifestyle changes made by the patient [49].
Table 2 Fatigue scores for patients and partners
Fatigue scores partners (M ± SD) Fatigue scores patients (M ± SD) p value Percentage fatigued partners Percentage fatigued patients
Time-0 18.7 ± 5.2 19.2 ± 5.56 .423 19 % 23 %
Time-1 20.0 ± 5.2 22.3 ± 6.7 .001 29 % 46 %
Time-2 19.7 ± 5.3 21.7 ± 7.0 .004 27 % 43 %
Time-3 19.1 ± 5.5 20.6 ± 6.5 .056 22 % 32 %
Statistically significant results (p< .05) are shown in italic
Higher scores indicate more fatigue
Time-0 preoperative measurement, Time-1 3months follow-up, Time-2 6months follow-up, Time-3 12months follow-up,FAS Fatigue Assessment Scale
(range 10–50)
Table 3 Estimates of fixed
effects for partners’ fatigue Predictor
a 95 % CI
B SE Sig. Lower bound Upper bound
Part I Timeb 0.64
Time-0 (intercept) 18.19 .40 .000 17.40 19.00
Time-1–time-0 .77 .48 .113 −.18 1.72
Time-2–time-0 1.18 .49 .016 .23 2.14
Time-3–time-0 .99 .46 .030 .10 1.89
Neuroticism .13 .06 .039 .01 .24
Trait anxiety .23 .09 .015 .05 .41
State anxiety .12 .08 .134 −.04 .29
Depressive symptoms .30 .05 <.0001 .20 .39
Part II Depressive symptoms: between .37 .08 <.0001 .22 .52
Depressive symptoms: within .26 .06 <.0001 .15 .37
Statistically significant results (p < .05) are shown in italic
Time-0 preoperative measurement, Time-1 3 months follow-up, Time-2 6 months follow-up, Time-3 12 months
follow-up
aAll predictors (except time) are grand-mean centered
bAnalysis of variance (ANOVA) type III test
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In this regard, future studies are encouraged to focus not
only more specifically on the experienced caregiver burden
and the consequences of this burden on the partners (e.g., their
biopsychosocial functioning, work ability/sick leave, and
health care consumption) but also to evaluate the influence of
the partners’ biopsychosocial functioning on patient outcomes
(e.g., the patients’ biopsychosocial functioning, health/illness
related-behaviors, and health care consumption).
Conclusion
Personality characteristics (i.e., high trait anxiety and neurot-
icism) and depressive symptoms were indicative of higher
levels of partners’ fatigue. Therefore, health professionals
are advised to be alert for partners with a vulnerable person-
ality and depressive symptoms as these partners may be prone
to develop problems. If needed, health professionals can refer
partners to a psychologist for adequate and timely treatment.
Providing care to the partners in need may not only lead to
better psychosocial functioning of the partner but may also
have favorable outcomes for the patient, via increased part-
ners’ engagement in the patient’s health.
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